Vericel (VCEL) Non Operating Income (2010 - 2026)
Vericel's (VCEL) quarterly Non Operating Income came in at $71000.0 in Q1 2026, up 69.05% year-on-year from $42000.0 in Q1 2025, and up 101.51% quarter-over-quarter from -$4.7 million in Q4 2025.
Vericel (VCEL) Non Operating Income (2010 - 2026) Analysis & Trends
Vericel has disclosed Non Operating Income across 17 years of filings, most recently posting $71000.0 for Q1 2026.
- Non Operating Income for Q1 2026 came in at $71000.0, up 69.05% year-over-year; the trailing twelve-month figure through Mar 2026 was -$1.5 million (down 120.54% YoY), and the FY2025 annual result was -$44000.0, down 100.73% from the prior year.
- Non Operating Income came in at $71000.0 for Q1 2026 at Vericel, up from -$4.7 million in the prior quarter.
- In the past five years, Non Operating Income ranged from a high of $5.9 million in Q4 2024 to a low of -$4.7 million in Q4 2025.
- The 5-year median for Non Operating Income is $140000.0 (2024), against an average of $476764.7.
- Across the five-year window, Non Operating Income surged 14100.0% in 2024 and sank 179.95% in 2025, its largest moves.
- Vericel's Non Operating Income stood at -$3000.0 in 2022, then jumped by 2833.33% to $82000.0 in 2023, then jumped by 7053.66% to $5.9 million in 2024, then sank by 179.95% to -$4.7 million in 2025, then soared by 101.51% to $71000.0 in 2026.
- The last three Non Operating Income figures came in at $71000.0 (Q1 2026), -$4.7 million (Q4 2025), and $1.6 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Op. Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | 5.75 Mn |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | - |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | 444,000.00 |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | 9.35 Mn |
| 10 | Vericel | 2.04 Bn | 1.90 Bn | 49.27 Mn | 71,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 71,000.00 |
| Dec 31, 2025 | -4.69 Mn |
| Sep 30, 2025 | 1.62 Mn |
| Jun 30, 2025 | 1.48 Mn |
| Mar 31, 2025 | 42,000.00 |
| Dec 31, 2024 | 5.87 Mn |
| Sep 30, 2024 | 140,000.00 |
| Jun 30, 2024 | 1.35 Mn |
| Mar 31, 2024 | -7,000.00 |
| Dec 31, 2023 | 82,000.00 |
| Sep 30, 2023 | -1,000.00 |
| Jun 30, 2023 | 941,000.00 |
| Mar 31, 2023 | 682,000.00 |
| Dec 31, 2022 | -3,000.00 |
| Sep 30, 2022 | 232,000.00 |
| Jun 30, 2022 | 119,000.00 |
| Mar 31, 2022 | 182,000.00 |
| Dec 31, 2021 | 228,000.00 |
| Sep 30, 2021 | -13,000.00 |
| Jun 30, 2021 | 15,000.00 |